The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled
trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related
symptoms and quality of life as well as leiomyoma and uterine size.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)